Dr Reddy’s shares fell sharply on Thursday after the company delayed commercial supplies of its semaglutide product due to a quality issue involving the active pharmaceutical ingredient (API). The company said patient safety and regulatory filings remain unaffected, while an investigation is underway to identify the root cause and restore supplies.
Ceigall India shares rise 4% after winning Rs 705 crore Arunachal Pradesh Frontier Highway project
Ceigall India shares rose 4% after securing a ₹704.7 crore MoRTH contract for the Frontier Highway in Arunachal Pradesh. The EPC project, awarded jointly with